Latest Breaking News On - Italfarmaco paolo bettica - Page 1 : comparemela.com

FDA Extends Review Time for Investigational Duchenne Agent Givinostat

Givinostat, a histone deacetylase inhibitor from Italfarmaco, was supported by data from the phase 3 EPIDYS study, a randomized, double-blind, placebo-controlled, multicenter trial investigating the agent vs placebo.